AERI

Aerie Pharmaceuticals, Inc.
AERI

Overview Fund Activity
Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

158 hedge funds and large institutions have $830M invested in Aerie Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
61
Closed
19
Calls
$3.8M
Puts
$5.06M
Net Calls
-$1.26M
Net Calls Change
-$2.71M

Top Buyers

1
WP
1
Woodline Partners
California
$38.5M
2
GIM
2
Granahan Investment Management
Massachusetts
$20.7M
3
Principal Financial Group
3
Principal Financial Group
Iowa
$9.46M
4
RCMNY
4
Rubric Capital Management (New York)
New York
$8.59M
5
ACM
5
Atika Capital Management
New York
$8.58M

Top Sellers

1
DM
1
Deerfield Management
New York
$8.83M
2
VOYA Investment Management
2
VOYA Investment Management
Georgia
$3.89M
3
First Manhattan
3
First Manhattan
New York
$0
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$3.58M
5
Bank of America
5
Bank of America
North Carolina
$47.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
MCM
176
Manchester Capital Management
Vermont
– -$2K -150 Closed
ASN
177
Advisory Services Network
Georgia
– -$1K -51 Closed
4 5 6 7
8